The company NewsGuard, which ranks news sites to counter what it deems misinformation, including stories that question COVID-19 vaccine safety and efficacy, received significant funding from a firm that represents some of the world’s biggest pharmaceutical companies.
Source: washingtontimes.com
Please follow and like us:
